ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
3,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
6,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
6,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
7,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
9,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
10,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
10,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
10,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
10,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10,5,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
10,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
10,7,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
10,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
11,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
12,1,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
12,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
13,1,Myasthenic syndrome,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
14,1,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
14,2,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
15,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
17,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
18,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
19,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
19,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
19,3,Oesophageal varices haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
19,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
20,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
20,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
20,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
20,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
21,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
21,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
21,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
21,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
22,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
23,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
24,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
24,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
25,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
25,2,Blood iron increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
25,3,Serum ferritin abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
26,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
27,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
27,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
28,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
29,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
31,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
31,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
31,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
32,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
33,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
34,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
34,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
34,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
35,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
36,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
36,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
36,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
37,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
38,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
38,2,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
38,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
39,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
39,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
39,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
39,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
39,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
39,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,1,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
41,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
41,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
43,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
44,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
45,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
46,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
46,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
47,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
48,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
48,2,Pancreatitis haemorrhagic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
48,3,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
49,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
49,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
50,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
51,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
52,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
53,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
54,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
55,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
56,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
56,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
57,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
57,2,Sideroblastic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
57,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
58,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
58,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
58,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
59,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
60,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,Y
61,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
61,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
62,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
63,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
64,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
65,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
66,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
67,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
67,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
68,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
68,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
68,3,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
69,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
70,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
70,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
70,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
71,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
71,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
73,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
73,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
73,3,Coronary artery insufficiency,Coronary artery disorders NEC,Coronary artery disorders,Card,N
73,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
74,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
74,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,4,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
75,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
76,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
77,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
77,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
77,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
78,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
79,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
80,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
80,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
81,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
82,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
82,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
83,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
83,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
83,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
84,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
85,1,Dysdiadochokinesis,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
85,2,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
86,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
86,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
87,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
87,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
88,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
88,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
89,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
89,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
89,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
90,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
91,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
91,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
91,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
92,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
92,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
92,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
92,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
93,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
93,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
94,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
94,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
95,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
96,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
97,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
97,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
98,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
99,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
100,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
101,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
101,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
102,1,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
102,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
102,3,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
102,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
103,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
104,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
104,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
104,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
105,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
106,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
107,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
107,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
108,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
109,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
110,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
110,2,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
111,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
112,1,Headache,Headaches NEC,Headaches,Nerv,N
112,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
112,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
112,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
113,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
113,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
114,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
115,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
115,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
115,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
115,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
115,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
116,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
117,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
118,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
118,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
118,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
119,1,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
119,2,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
120,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
121,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
122,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
122,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
122,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
123,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
124,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
125,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
125,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
126,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
126,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
127,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
127,2,Persecutory delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
128,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
129,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
129,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
130,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
131,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
132,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
133,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
134,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
134,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
135,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
135,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
135,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
135,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
136,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
137,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
137,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
137,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
138,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
138,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
139,1,Headache,Headaches NEC,Headaches,Nerv,N
139,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
139,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
139,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
140,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
141,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
141,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
142,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
143,1,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
144,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
144,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
145,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
145,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
146,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
146,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
147,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
147,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
148,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
148,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
148,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
148,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
149,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
149,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
150,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
150,2,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,Y
151,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
152,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
152,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
152,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
153,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
153,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
154,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
154,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
155,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
156,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
156,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
157,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
157,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
157,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
158,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
159,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
159,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
160,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
161,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
162,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
163,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
164,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
165,1,Trichoglossia,Tongue disorders,Tongue conditions,Gastr,N
166,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
167,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
168,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
168,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
169,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
170,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
170,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
171,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
172,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
172,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
173,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
173,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
173,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
173,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
174,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
175,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
176,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
177,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
178,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
179,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
179,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
179,3,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
180,1,Sideroblastic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
180,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
181,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
182,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
183,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
184,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
184,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
185,1,Sideroblastic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
186,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
187,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
187,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
188,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
188,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
188,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
189,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
189,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
189,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
190,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
191,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
192,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
192,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
192,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
192,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
194,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
195,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
196,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
196,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
197,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
197,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
197,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
198,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
199,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
200,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
201,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
201,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
202,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
203,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
204,1,Reticulocytopenia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
205,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
206,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
206,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
207,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
207,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
208,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
209,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
210,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
210,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
210,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
210,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
211,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
211,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
211,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
211,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
212,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
212,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
213,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
213,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
214,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
215,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
216,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
216,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
217,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
218,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
219,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
220,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
221,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
222,1,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,Y
223,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
223,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
223,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
224,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
224,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
224,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
225,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
225,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
226,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
226,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
226,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
226,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
226,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
226,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
226,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
227,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
228,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
229,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
229,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
229,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
229,4,Headache,Headaches NEC,Headaches,Nerv,N
229,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
229,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
229,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
230,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
230,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
231,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
231,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
232,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
233,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
234,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
234,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
234,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
235,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
236,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
236,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
237,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
237,2,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
238,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
238,2,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
238,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
238,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
238,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
239,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
239,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
240,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
240,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
240,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
241,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
241,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
241,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
242,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
243,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
244,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
245,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
245,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
246,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
246,2,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
247,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
248,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
249,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
250,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
250,2,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
250,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
251,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
252,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
253,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
253,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
254,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
255,1,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
255,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
256,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
257,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
258,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
259,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
259,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
259,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
259,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
260,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
260,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
260,3,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
261,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
261,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
262,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
263,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
264,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
265,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
266,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
267,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
268,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
269,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
269,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
269,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
270,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
271,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
272,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
272,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
273,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
273,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
274,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
274,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
275,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
276,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
276,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
277,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
278,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
278,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
278,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
278,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
279,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
279,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
280,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
280,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
280,3,Retinitis pigmentosa,Retinal disorders congenital,Eye disorders congenital,Cong,N
281,1,Anticoagulation drug level,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
281,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
281,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
281,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
282,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
283,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
284,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
285,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
286,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
287,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
287,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
288,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
288,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
288,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
289,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
289,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
289,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
290,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
290,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
291,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
291,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
292,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
292,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
293,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
293,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
293,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
293,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
294,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
294,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
294,3,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
294,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
294,5,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
294,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
295,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
296,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
296,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
296,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
297,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
298,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
298,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
299,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
300,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
300,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
301,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
302,1,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
302,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
302,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
303,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
304,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
304,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
304,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
305,1,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
305,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
305,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
306,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
307,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
308,1,Labyrinthitis,Ear infections,Infections - pathogen unspecified,Infec,N
309,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
309,2,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
310,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
310,2,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
311,1,Deafness,Hearing losses,Hearing disorders,Ear,N
312,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
313,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
313,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
314,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
314,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
314,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
314,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
315,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
315,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
315,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
315,5,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
315,6,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
316,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
316,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
316,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
316,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
316,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
317,1,Trichoglossia,Tongue disorders,Tongue conditions,Gastr,N
318,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
319,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
320,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
321,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
322,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
323,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
323,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
324,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
325,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
325,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
326,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
327,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
328,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
328,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
328,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
329,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
330,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
331,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
332,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
333,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
333,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
334,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
335,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
336,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
337,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
338,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
339,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
339,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
339,3,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
339,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
340,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
340,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
340,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
341,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
342,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
342,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
343,1,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
343,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
343,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
343,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
344,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
345,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
346,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
347,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
347,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
347,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
348,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
349,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
349,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
349,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
350,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
351,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
352,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
353,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
353,2,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
354,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
354,2,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
354,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
354,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
354,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
355,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
355,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
355,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
356,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
357,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
358,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
359,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
359,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
359,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
359,4,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
360,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
361,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
361,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
362,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
363,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
364,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
364,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
365,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
365,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
365,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
366,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
366,2,Oxygen consumption increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
366,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
366,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
366,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
366,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
367,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
367,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
368,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
368,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
369,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
369,2,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
369,3,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
370,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
371,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
372,1,Deafness,Hearing losses,Hearing disorders,Ear,N
372,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
373,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
374,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
375,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
376,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
377,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
378,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
378,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
379,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
380,1,Bone marrow transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
380,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
380,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
381,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
382,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
383,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
383,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
383,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
383,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
384,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
385,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
386,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
387,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
387,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
387,3,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
388,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
388,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
388,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
388,4,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
389,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
389,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
389,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
390,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
391,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
392,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
392,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
392,3,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
393,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
393,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
394,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
394,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
394,3,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
395,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
396,1,Auditory nerve disorder,Auditory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
397,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
397,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
398,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
399,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
399,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
399,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
399,4,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
399,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
400,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
401,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
402,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
402,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
402,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
403,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
404,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
404,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
405,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
405,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
406,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
407,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
407,2,Deafness,Hearing losses,Hearing disorders,Ear,N
407,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
407,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
407,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
407,6,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
407,7,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
408,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
409,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
410,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
411,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
411,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
412,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
413,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
413,2,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
413,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
414,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
415,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
416,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
417,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
417,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
417,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
418,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
419,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
419,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
419,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
419,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
419,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
420,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
420,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
421,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
422,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
423,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
424,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
425,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
426,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
426,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
426,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
427,1,Biopsy bone marrow abnormal,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
427,2,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
427,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
428,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
428,2,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
429,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
430,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
431,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
431,2,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
432,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
432,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
432,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
432,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
433,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
433,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
434,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
435,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
435,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
436,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
437,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
438,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
439,1,Deafness,Hearing losses,Hearing disorders,Ear,N
439,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
439,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
440,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
440,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
440,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
441,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
441,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
441,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
442,1,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
443,1,Staphylococcal osteomyelitis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
444,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
445,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
445,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
445,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
446,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
447,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
448,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
449,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
449,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
450,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
450,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
450,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
450,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
451,1,Aortic valve stenosis,Aortic valvular disorders,Cardiac valve disorders,Card,N
451,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
451,3,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
451,4,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
451,5,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
451,6,Minimum inhibitory concentration,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
451,7,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
451,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
451,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
452,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
452,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
453,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
454,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
454,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
454,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
455,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
456,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
457,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
458,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
459,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
459,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
459,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
459,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
459,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
459,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
459,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
460,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
461,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
462,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
463,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
463,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
464,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
465,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
465,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
465,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
465,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
466,1,Metamorphopsia,Visual disorders NEC,Vision disorders,Eye,N
466,2,Migraine with aura,Migraine headaches,Headaches,Nerv,N
466,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
467,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
468,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
469,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
470,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
471,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
472,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
473,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
473,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
474,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
475,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
476,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
477,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
477,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
477,3,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
477,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
477,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
477,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
478,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
479,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
480,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
481,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
482,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
483,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
484,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
484,2,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
484,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
485,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
485,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
485,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
486,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
486,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
486,3,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
486,4,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
486,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
486,6,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
486,7,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
486,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
487,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
487,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
488,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
489,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
490,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
491,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
491,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
491,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
491,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
491,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
492,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
493,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
493,2,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
493,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
493,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
493,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
493,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
494,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
494,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
495,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
496,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
497,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
497,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
498,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
499,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
500,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
500,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
500,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
500,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
500,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
500,6,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
500,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
500,8,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
501,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
502,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
502,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
503,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
504,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
505,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
505,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
506,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
507,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
507,2,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
507,3,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
508,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
509,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
509,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
510,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
510,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
510,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
511,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
512,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
513,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
514,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
514,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
515,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
515,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
516,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
516,2,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
516,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
516,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
516,5,Headache,Headaches NEC,Headaches,Nerv,N
516,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
516,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
516,8,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
516,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
517,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
517,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
518,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
518,2,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
519,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
519,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
519,3,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
520,1,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
521,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
521,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
521,3,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
522,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
523,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
523,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
523,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
523,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
524,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
525,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
525,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
526,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
526,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
527,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
527,2,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
527,3,Dysdiadochokinesis,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
527,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
527,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
527,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
527,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
528,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
528,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
528,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
528,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
528,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
528,6,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
529,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
530,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
530,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
530,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
530,4,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
530,5,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
530,6,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
530,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
530,8,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
530,9,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
530,10,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
530,11,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
530,12,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
530,13,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
530,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
530,15,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
530,16,Headache,Headaches NEC,Headaches,Nerv,N
530,17,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
530,18,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
530,19,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
530,20,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
530,21,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
530,22,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
530,23,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
530,24,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
530,25,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
530,26,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
530,27,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
530,28,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
530,29,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
530,30,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
530,31,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
530,32,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
530,33,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
530,34,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
530,35,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
530,36,Tension headache,Headaches NEC,Headaches,Nerv,N
530,37,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
530,38,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
530,39,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
530,40,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
530,41,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
530,42,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
530,43,Wound complication,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
531,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
531,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
531,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
531,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
532,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
532,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
533,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
534,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
534,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
534,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
535,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
536,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
537,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
537,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
537,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
538,1,Hypochloraemia,Chloride imbalance,Electrolyte and fluid balance conditions,Metab,N
538,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
539,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
540,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
540,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
541,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
542,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
543,1,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
544,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
545,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
546,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
546,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
547,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
547,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
548,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
548,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
548,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
549,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
549,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
549,3,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
549,4,Headache,Headaches NEC,Headaches,Nerv,N
549,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
549,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
549,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
549,8,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
550,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
550,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
550,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
550,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
550,5,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
550,6,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
550,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
551,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
551,2,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
551,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
551,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
551,5,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
551,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
551,7,Splenic embolism,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
551,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
552,1,Radial nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
553,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
553,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
553,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
553,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
553,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
553,6,Headache,Headaches NEC,Headaches,Nerv,N
553,7,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
553,8,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
553,9,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
553,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
553,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
553,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
553,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
553,14,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
553,15,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
553,16,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
553,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
554,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
554,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
555,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
556,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
557,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
557,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
557,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
557,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
558,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
559,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
559,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
560,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
561,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
561,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
561,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
562,1,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
562,2,Oscillopsia,Visual disorders NEC,Vision disorders,Eye,N
562,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
563,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
564,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
565,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
565,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
566,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
567,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
567,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
567,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
568,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
568,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
568,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
569,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
569,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
569,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
569,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
570,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
571,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
571,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
572,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
573,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
574,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
574,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
575,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
576,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
577,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
577,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
578,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
579,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
579,2,Hyperlactacidaemia,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
580,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
581,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
581,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
581,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
582,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
582,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
582,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
583,1,Central hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
583,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
583,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
584,1,Central hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
584,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
584,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
585,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
586,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
586,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
586,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
587,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
587,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
587,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
588,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
589,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
589,2,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
589,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
590,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
591,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
592,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
592,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
592,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
593,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
593,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
593,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
594,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
594,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
595,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
595,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
595,3,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
595,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
595,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
595,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
595,7,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
595,8,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
595,9,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
595,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
595,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
596,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
597,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
598,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
598,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
599,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
599,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
599,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
599,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
599,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
599,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
599,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
599,8,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
599,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
599,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
600,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
600,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
601,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
602,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
602,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
603,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
603,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
604,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
604,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
604,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
604,4,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
604,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
604,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
604,7,Periprosthetic fracture,Musculoskeletal procedural complications,Procedural related injuries and complications NEC,Inj&P,N
604,8,Sinusitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
605,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
605,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
605,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
605,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
606,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
607,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
608,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
609,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
609,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
610,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
611,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
612,1,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
612,2,Optic disc hyperaemia,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
612,3,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
612,4,Papillary muscle haemorrhage,Myocardial disorders NEC,Myocardial disorders,Card,N
612,5,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
612,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
612,7,Visual field defect,Visual field disorders,Vision disorders,Eye,N
613,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
614,1,Normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
614,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
614,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
615,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
616,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,Y
617,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
617,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
618,1,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
618,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
619,1,Convulsive threshold lowered,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
619,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
620,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
620,2,Optic disc hyperaemia,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
620,3,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
621,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
622,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
623,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
624,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
625,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
625,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
625,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
626,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
627,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
628,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
628,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
628,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
629,1,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
630,1,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
630,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
630,3,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
630,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
630,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
631,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
631,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
631,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
631,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
632,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
633,1,Catheter site induration,Implant and catheter site reactions,Administration site reactions,Genrl,N
633,2,Catheter site swelling,Implant and catheter site reactions,Administration site reactions,Genrl,N
634,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
635,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
636,1,Trichoglossia,Tongue disorders,Tongue conditions,Gastr,N
637,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
637,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
637,3,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
637,4,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
637,5,Coating in mouth,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
637,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
637,7,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
637,8,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
637,9,Plicated tongue,Tongue disorders,Tongue conditions,Gastr,N
638,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
638,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
639,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
640,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
641,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
641,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
641,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
642,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
643,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
643,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
644,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
644,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
644,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
645,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
646,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
646,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
647,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
648,1,Post stroke seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
649,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
649,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
649,3,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
649,4,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
649,5,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
649,6,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
650,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
650,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
650,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
650,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
651,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
651,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
651,3,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
651,4,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
651,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
652,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
652,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
653,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
654,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
655,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
656,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
657,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
658,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
659,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
660,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
661,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
662,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
663,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
664,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
665,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
666,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
666,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
666,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
667,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
668,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
669,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
670,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
671,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
672,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
672,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
672,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
673,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
674,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
675,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
676,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
677,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
677,2,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
677,3,Optic nerve disorder,Visual pathway disorders,Vision disorders,Eye,N
678,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
679,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
680,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
680,2,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
681,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
681,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
681,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
681,4,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
681,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
682,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
682,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
682,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
683,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
684,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
685,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
686,1,Trichoglossia,Tongue disorders,Tongue conditions,Gastr,N
687,1,Product monitoring error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
687,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
687,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
688,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
689,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
689,2,Tension headache,Headaches NEC,Headaches,Nerv,N
690,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
691,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
692,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
692,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
693,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
694,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
694,2,Haematological malignancy,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
694,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
695,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
696,1,Trichoglossia,Tongue disorders,Tongue conditions,Gastr,N
697,1,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
698,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
698,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
698,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
699,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
700,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
701,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
701,2,Eosinophilic pneumonia,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
702,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
702,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
703,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
704,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
704,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
705,1,Headache,Headaches NEC,Headaches,Nerv,N
705,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
706,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
706,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
707,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
708,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
708,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
709,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
710,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
711,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
712,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
712,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
712,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
712,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
712,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
713,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
714,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
714,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
715,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
715,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
715,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
716,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
717,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
717,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
718,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
719,1,Retinopathy hypertensive,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
720,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
721,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
722,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
722,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
722,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
722,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
723,1,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
724,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
725,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
726,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
726,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
726,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
726,4,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
727,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
727,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
727,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
728,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
729,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
730,1,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
730,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
730,3,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
730,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
730,5,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
730,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
731,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
731,2,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
731,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
731,4,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
732,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
733,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
734,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
735,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
736,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
737,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
737,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
738,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
739,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
739,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
740,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
741,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
741,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
741,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
741,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
742,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
742,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
742,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
742,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
742,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
742,6,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
742,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
743,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
743,2,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
743,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
743,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
744,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
744,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
745,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
745,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
745,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
745,4,Myoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
746,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
746,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
747,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
748,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
748,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
748,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
748,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
749,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
750,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
751,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
752,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
753,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
753,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
753,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
753,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
754,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
755,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
755,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
756,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
757,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
758,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
758,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
759,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
759,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
760,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
761,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
762,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
762,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
763,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
763,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
763,3,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
763,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
763,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
764,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
765,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
765,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
765,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
765,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
765,5,Seizure like phenomena,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
766,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
766,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
766,3,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
767,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
768,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
768,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
769,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
770,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
771,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
771,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
771,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
771,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
771,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
772,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
773,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
773,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
774,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
774,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
774,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
775,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
775,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
776,1,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
776,2,Tonic convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
777,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
778,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
778,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
778,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
779,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
780,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
780,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
781,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
782,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
783,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
784,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
785,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
786,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
786,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
787,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
788,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
789,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
789,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
789,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
790,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
791,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
792,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
793,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
794,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
794,2,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
794,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
794,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
794,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
794,6,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
794,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
794,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
794,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
795,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
796,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
797,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
798,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
799,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
799,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
799,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
799,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
799,5,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
800,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
800,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
800,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
800,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
800,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
800,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
801,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
801,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
802,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
803,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
803,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
804,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
804,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
804,3,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
805,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
806,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
806,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
806,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
807,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
808,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
809,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
809,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
810,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
811,1,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
812,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
813,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
814,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
815,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
815,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
816,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
816,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
817,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
817,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
818,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
819,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
819,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
819,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
820,1,Change in seizure presentation,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
820,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
821,1,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
821,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
821,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
822,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
823,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
824,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
824,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
824,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
825,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
825,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
825,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
825,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
825,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
825,6,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
825,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
825,8,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
825,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
825,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
825,11,Transaminases abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
826,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
826,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
826,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
826,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
827,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
828,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
829,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
830,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
831,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
831,2,Acne,Acnes,Skin appendage conditions,Skin,N
831,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
831,4,Headache,Headaches NEC,Headaches,Nerv,N
831,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
831,6,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
831,7,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
831,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
832,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
832,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
833,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
834,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
835,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
836,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
837,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
837,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
838,1,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
839,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
839,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
839,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
839,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
839,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
840,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
841,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
842,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
843,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
844,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
844,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
845,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
845,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
846,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
847,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
847,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
848,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
849,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
850,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
851,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
852,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
853,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
853,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
854,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
855,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
856,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
857,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
858,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
859,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
860,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
861,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
861,2,Deafness,Hearing losses,Hearing disorders,Ear,N
861,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
861,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
862,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
862,2,Deafness,Hearing losses,Hearing disorders,Ear,N
862,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
862,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
862,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
863,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
863,2,Deafness,Hearing losses,Hearing disorders,Ear,N
863,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
863,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
864,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
865,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
865,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
866,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
866,2,Deafness,Hearing losses,Hearing disorders,Ear,N
866,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
866,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
866,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
867,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
867,2,Deafness,Hearing losses,Hearing disorders,Ear,N
867,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
867,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
868,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
868,2,Deafness,Hearing losses,Hearing disorders,Ear,N
868,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
868,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
869,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
869,2,Deafness,Hearing losses,Hearing disorders,Ear,N
869,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
869,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
869,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
870,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
871,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
872,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
872,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
873,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
873,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
873,3,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
874,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
874,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
874,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
874,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
875,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
875,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
876,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
876,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
876,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
876,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
876,5,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
876,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
876,7,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
877,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
878,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
879,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
879,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
880,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
880,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
880,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
880,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
880,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
880,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
880,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
881,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
882,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
883,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
884,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
884,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
885,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
886,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
887,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
888,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
889,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
890,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
890,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
891,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
892,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
893,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
893,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
894,1,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
894,2,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
894,3,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
894,4,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
894,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
894,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
894,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
895,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
896,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
897,1,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
897,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
897,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
897,4,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
897,5,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
897,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
897,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
898,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
898,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
898,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
898,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
898,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
898,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
898,7,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
898,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
898,9,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
898,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
899,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
900,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
901,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
902,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
902,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
902,3,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
902,4,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
902,5,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
902,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
902,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
902,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
902,9,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
903,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
904,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
904,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
904,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
904,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
904,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
904,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
904,7,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
904,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
904,9,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
904,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
905,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
906,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
907,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
907,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
908,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
908,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
909,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
909,2,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
909,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
909,4,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
909,5,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
909,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
909,7,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
909,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
910,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
911,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
912,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
913,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
914,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
915,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
915,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
916,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
916,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
917,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
917,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
918,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
918,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
918,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
919,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
919,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
919,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
919,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
919,5,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
920,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
920,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
921,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
921,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
921,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
921,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
922,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
923,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
924,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
924,2,Mixed deafness,Hearing losses,Hearing disorders,Ear,N
925,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
926,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
927,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
928,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
928,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
928,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
929,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
930,1,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
930,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
931,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
932,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
932,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
933,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
933,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
934,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
934,2,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
934,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
934,4,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
934,5,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
934,6,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
934,7,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
934,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
934,9,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
934,10,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
934,11,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
934,12,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
934,13,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
934,14,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
935,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
936,1,Headache,Headaches NEC,Headaches,Nerv,N
936,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
936,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
936,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
937,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
938,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
939,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
940,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
941,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
941,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
941,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
942,1,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
942,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
942,3,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
942,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
942,5,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,1,Hyperuricaemia,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
943,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
944,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
945,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,Y
946,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
947,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
948,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
948,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
949,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
950,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
950,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
951,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
952,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
953,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
954,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
955,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
956,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
956,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
957,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
958,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
959,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
960,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
961,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
961,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
962,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
963,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
963,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
963,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
964,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
965,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
965,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
965,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
965,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
966,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
967,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
968,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
969,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
970,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
970,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
970,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
970,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
971,1,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
971,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
971,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
971,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
972,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
973,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
974,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
974,2,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
975,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
975,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
975,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
976,1,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
977,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
978,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
979,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
980,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
980,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
980,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
980,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
980,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
980,6,Death,Death and sudden death,Fatal outcomes,Genrl,N
980,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
980,8,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
980,9,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
980,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
980,11,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
980,12,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
980,13,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
980,14,Headache,Headaches NEC,Headaches,Nerv,N
980,15,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
980,16,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
980,17,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
980,18,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
980,19,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
980,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
980,21,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
980,22,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
980,23,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
980,24,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
980,25,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
980,26,Skin candida,Candida infections,Fungal infectious disorders,Infec,N
980,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
981,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
982,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
982,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
983,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
983,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
983,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
983,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
983,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
983,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
983,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
984,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
984,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
985,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
986,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
987,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
988,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
988,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
989,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
990,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
991,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
992,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
993,1,Hyperlactacidaemia,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
994,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
995,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
996,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
997,1,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
998,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
999,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1000,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1000,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1001,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1002,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1003,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1003,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1004,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1005,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1005,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1006,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1006,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1007,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1008,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1008,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1009,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1010,1,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
1010,2,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
1011,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
1012,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1012,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1012,3,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1012,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1012,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1012,6,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1012,7,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1012,8,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1012,9,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1012,10,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1012,11,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1012,12,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1012,13,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1012,14,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1012,15,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1012,16,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1012,17,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1012,18,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1013,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1014,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1014,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1014,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1014,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1014,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1014,6,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1015,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1015,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1015,3,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1016,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1016,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1016,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1016,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1016,5,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1017,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1017,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1017,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1017,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1017,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1017,6,Poisoning deliberate,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1017,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1017,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1017,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1017,10,Self-medication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1017,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1018,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1019,1,Symmetrical drug-related intertriginous and flexural exanthema,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1020,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1020,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1020,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1020,4,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1020,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1021,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1022,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1023,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1024,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1024,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1024,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1025,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1026,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1027,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1028,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1028,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1029,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1030,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1031,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1031,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1032,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1033,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
1034,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1035,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1036,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1037,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1037,2,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
1037,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1038,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
1039,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1040,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1041,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1042,1,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
